Search research articles
Contact Us
Filters
Showing results (21-30 of 116) with videos related to
Page
of 12
Sort By:
Cleveland Clinic Journal of Medicine
|
February 19, 2000
Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes
M T Roe, S K Sapp, A M Lincoff
Circulation
|
October 1, 1994
Local drug delivery for the prevention of restenosis. Fact, fancy, and future
A M Lincoff, E J Topol, S G Ellis
The Journal of Thoracic and Cardiovascular Surgery
|
January 29, 2000
Abciximab (ReoPro) removal during cardiopulmonary bypass with a hemoconcentrator
S R Steinhubl, S A Moore, A M Lincoff
Journal of the American College of Cardiology
|
December 1, 1994
Cell adhesion molecules in coronary artery disease
Y Jang, A M Lincoff, E F Plow, et al.
The American Journal of Cardiology
|
May 4, 2000
The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends
K R Campbell, E M Ohman, W Cantor, et al.
American Heart Journal
|
October 20, 1998
Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: pathophysiologic foundation and clinical findings
N S Kleiman, A M Lincoff, E M Ohman, et al.
European Heart Journal
|
November 1, 1995
An overview of the results of the EPIC trial
R M Califf, A M Lincoff, J E Tcheng, et al.
Physics in Medicine and Biology
|
June 1, 1982
Role of longitudinal diffusion in the extravascular pulmonary space on parameter estimates derived from data of multiple indicator dilution
H S Borovetz, W H Inskeep, A M Lincoff, et al.
Clinical Cardiology
|
May 1, 1996
Restenosis--an open file
M Gottsauner-Wolf, D J Moliterno, A M Lincoff, et al.
Heart (British Cardiac Society)
|
January 3, 2006
Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk
D P Chew, D L Bhatt, A M Lincoff, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 116) with videos related to
Sort By:
Page
of 12
Cleveland Clinic Journal of Medicine
|
February 19, 2000
Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes
M T Roe, S K Sapp, A M Lincoff
Circulation
|
October 1, 1994
Local drug delivery for the prevention of restenosis. Fact, fancy, and future
A M Lincoff, E J Topol, S G Ellis
The Journal of Thoracic and Cardiovascular Surgery
|
January 29, 2000
Abciximab (ReoPro) removal during cardiopulmonary bypass with a hemoconcentrator
S R Steinhubl, S A Moore, A M Lincoff
Journal of the American College of Cardiology
|
December 1, 1994
Cell adhesion molecules in coronary artery disease
Y Jang, A M Lincoff, E F Plow, et al.
The American Journal of Cardiology
|
May 4, 2000
The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends
K R Campbell, E M Ohman, W Cantor, et al.
American Heart Journal
|
October 20, 1998
Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: pathophysiologic foundation and clinical findings
N S Kleiman, A M Lincoff, E M Ohman, et al.
European Heart Journal
|
November 1, 1995
An overview of the results of the EPIC trial
R M Califf, A M Lincoff, J E Tcheng, et al.
Physics in Medicine and Biology
|
June 1, 1982
Role of longitudinal diffusion in the extravascular pulmonary space on parameter estimates derived from data of multiple indicator dilution
H S Borovetz, W H Inskeep, A M Lincoff, et al.
Clinical Cardiology
|
May 1, 1996
Restenosis--an open file
M Gottsauner-Wolf, D J Moliterno, A M Lincoff, et al.
Heart (British Cardiac Society)
|
January 3, 2006
Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk
D P Chew, D L Bhatt, A M Lincoff, et al.
Page
of 12